TNF and soft tissue sarcoma: We reported that administration of low-dose TNF-α, in combination with PEGylated liposomal doxorubicin (PLD), provided a significantly higher DXR delivery in soft tissue sarcoma in BN rats, resulting in a stable tumor volume compared to treatment without TNF-α [72,73].